← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2008First marketed drug
Mar 19, 1963First NDA
Mar 19, 1963Last known activity
Dec 17, 2025
Timeline
1940s
- Jan 1, 1943
Almirall— Founded
1970s
- Aug 6, 1971
fluorouracil— NDA Secondary Org
1990s
- Dec 10, 1999
tretinoin— Marketing Organization
2010s
- Jan 1, 2013
Aqua Pharmaceuticals— Acquired
- Dec 2, 2015
Polichem S.A.— Acquired
2020s
- Dec 14, 2020
tirbanibulin— NDA Organization
Drugs by trial phase (34 distinct, 48 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (6 own, 4 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (13)
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (50)
- NCT07311564Lead sponsorPhase 2Dec 17, 2025
- NCT07311564OfficialPhase 2Dec 17, 2025
- NCT07273656CollaboratorPhase 3Nov 30, 2025
- NCT07151937Lead sponsorPhase 2Sep 30, 2025
- NCT07151937OfficialPhase 2Sep 30, 2025
- NCT06928246CollaboratorPhase 1Jul 17, 2025
- NCT06906497CollaboratorPhase 4Jul 2, 2025
- NCT06526182OfficialPhase 3Jul 3, 2024
- NCT06526182Lead sponsorPhase 3Jul 3, 2024
- NCT06135415Lead sponsorPhase 3Dec 31, 2023
- NCT06200597Lead sponsorPhase 1Dec 5, 2023
- NCT06026358CollaboratorPhase 4Oct 31, 2023
- NCT05990725Lead sponsorPhase 3Oct 30, 2023
- NCT05916365Lead sponsorPhase 3May 23, 2023
- NCT05916365Overall official - principal investigatorPhase 3May 23, 2023
Details
- Founded
- Barcelona, ES Jan 1, 1943
- First NDA
- Mar 19, 1963
- Last known activity
- Dec 17, 2025